|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
08037 CH BIOTECH SER
Nominal 
0.425 +0.005 (+1.190%) | 2023/12 - Final HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Net Cash from / (used in) Operating Activities | 195,193 | 482,748 | 40,505 | 421,999 | (30,306) |
| Net Cash from / (used in) Investing Activities | (67,531) | (256,311) | (8,124) | (126,248) | (100,237) |
| Net Cash from / (used in) Financing Activities | (146,167) | (281,959) | (266,611) | 43,937 | 23,074 |
| Increase / (Decrease) in Cash & Cash Equivalents | (18,505) | (55,522) | (234,230) | 339,688 | (107,469) |
| Cash & Cash Equivalents at beginning of period | 92,770 | 150,554 | 384,539 | 45,518 | 154,479 |
| Effect of Foreign Exchange Rate Changes | (2,178) | (2,262) | 245 | (667) | (1,492) |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 72,087 | 92,770 | 150,554 | 384,539 | 45,518 |
| Remarks: | Real time quote last updated: 06/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -79,917,000 |
| %Change | 162.160% |
| EPS / (LPS) | HKD -0.083 |
| NBV Per Share ($) | HKD 0.405 |